Consumer Health Product Market Fraud During Pandemic Didn’t Surprise US FDA – Woodcock

“This type of activity always emerges during a crisis where people will take advantage of others’ desperation and fear,” says acting Commissioner Janet Woodcock in FDLI conference keynote. Regulated industries’ data are needed to continue responding to COVID-19 and prepare for “what comes next.”

More from Regulation

More from Policy & Regulation